Intelligent Bio Solutions Inc.
13F holders, Q3 2024 (September 30)8holders
2new positions
1sold out
$1.73avg. 13F price*
At the end of Q3 2024, 8 institutions reported holding Intelligent Bio Solutions Inc. in their 13F filings, unchanged from Q2 2024. 2 opened new positions and 1 sold out. The largest holders were Alyeska Investment Group, L.P. ($357K), Geode Capital Management, LLC ($39K) and Vanguard Group Inc. ($27K).
- Company
- Intelligent Bio Solutions Inc.
- CUSIP
- 36151G600
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $357K |
| Exits | 1 | $161K |
All 13F filers, Q2 2024 → Q3 2024: 210,310 shares bought and 193,536 shares sold, net +16,774 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 8 holders
| Alyeska Investment Group, L.P. | 0.00% | New | 206,199 | $357K |
| Geode Capital Management, LLC | 0.00% | Add +19.1% | 22,706 | $39K |
| Vanguard Group Inc. | 0.00% | No change | 15,485 | $27K |
| ADAR1 Capital Management, LLC | 0.00% | Reduce -95.0% | 5,389 | $9K |
| UBS Group AG | 0.00% | Reduce -81.4% | 1,551 | $3K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +62.5% | 1,063 | $2K |
| Bank of America Corp. | 0.00% | No change | 25 | $43 |
| Royal Bank of Canada | 0.00% | New | 55 | $0 |
"% of holder's portfolio" is INTELLIGENT BIO SOLUTIONS IN's weight in each manager's 13F, not the share of Intelligent Bio Solutions Inc. the manager owns.